Good news! Suzhou Hui Therapy has received 1 million yuan in funding support for its leading incubation project in the park.

Recently, Huitherapy's "Research and Industrialization of Nucleic Acid (mRNA) Drugs Based on Cell Membrane Delivery Platform Technology" was awarded the "Leading Talent of Suzhou Industrial Park" by the Science and Technology Innovation Committee of the park. This selection fully reflects the technological innovation advantages and strong strength of Huihui Biotechnology in the field of mRNA drug research and development, as well as the high recognition of Huihui Biotechnology's innovation ability by society.

The project was successfully signed on November 25, 2021

Technology Leading Talents Innovation and Entrepreneurship Project

The Suzhou Industrial Park Science and Technology Leading Talent Innovation and Entrepreneurship Project focuses on the leading and emerging industries of the park. Within three years, more than 100 science and technology leading talents (including growth projects, incubation projects, and innovation projects) from Suzhou Industrial Park will be selected and introduced annually, including no less than 40 nanotechnology leading talents.

For the selected leading projects, growth projects, incubation projects, and innovation projects of science and technology leaders in Suzhou Industrial Park, special funds such as project start-up capital, venture capital, follow-up venture capital unified loan platform support, and project loan guarantee will be provided at four levels, as well as key support such as project funding, rental of office space, rental of housing, purchase of housing subsidies, and resettlement of family members according to the treatment of park residents. Specific measures will be implemented in accordance with the relevant provisions of the "Implementation Opinions of the Park Working Committee on Promoting the Innovation and Entrepreneurship Project of Science and Technology Leaders in Suzhou Industrial Park" (Su Yuan Gong [2015] No. 28).